Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

FTV earnings analysis

Filed July 29, 2026 · Our reading of the company's report

The latest report

The supplied 10-Q excerpt does not include the income statement, segment data, balance sheet, or cash-flow statements, so revenue, margins, EPS, free cash flow, and period-over-period trends cannot be verified from the…

Read full summary

The supplied 10-Q excerpt does not include the income statement, segment data, balance sheet, or cash-flow statements, so revenue, margins, EPS, free cash flow, and period-over-period trends cannot be verified from the filing text provided. The principal disclosed capital-allocation item was the repurchase of 3,360,283 shares at $59.54 per share during Q2. Management reported no material risk-factor changes for the quarter ended July 3, 2026 and stated that disclosure controls were effective.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

65% Gross margin Operating margin Jul 2022 Apr 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Jul 2022 Jul 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

What stood out

  • Meaningful quarterly share repurchases

    Fortive repurchased 3,360,283 shares during the quarter ended July 3, 2026, at an average price of $59.54 per share. The Board also authorized 14.4 million new shares on May 4, 2026.

  • Repurchase capacity remains available

    After quarterly repurchases, the General Share Repurchase Program had 17.7 million shares available and the Special Share Repurchase Program had $66.7 million available as of July 3, 2026.

  • Controls assessed as effective

    Management concluded that disclosure controls and procedures were effective as of July 3, 2026, and reported no material changes in internal control over financial reporting during the quarter.

What to watch

  • No material risk-factor updates

    The filing states that there were no material changes in risk factors during the quarter ended July 3, 2026. Accordingly, this 10-Q does not identify a newly escalated risk relative to the 2025 Form 10-K.

  • Buyback execution remains discretionary

    The $66.7 million Special Share Repurchase Program balance and 17.7 million-share General Program authorization may be suspended or discontinued at any time by the Board, limiting certainty around future capital returns.

Management's outlook

The supplied 10-Q excerpt contains no quantitative revenue or EPS outlook. Quantitative guidance appears to have been addressed in the contemporaneous earnings release rather than this filing excerpt.

Earlier filings 4

10-Q · April 30, 2026

Fortive Corporation reported its Q1 2026 results, showing a revenue of $1.07 billion and an adjusted EPS of $0.70, both reflecting positive year-over-year growth but falling short of analyst expectations. Management…

10-K · February 25, 2026

Fortive’s 10-K emphasizes the “Fortive Accelerated” strategy powered by the Fortive Business System (FBS) to deliver faster profitable growth, disciplined capital allocation and investor trust. The company operates two…

10-K · February 25, 2025

Fortive’s 10-K emphasizes a portfolio strategy across three segments (Intelligent Operating Solutions, Precision Technologies, Advanced Healthcare Solutions), continued deployment of the Fortive Business System (FBS)…

10-Q · July 24, 2024

Fortive reported quarterly sales of $1,552.4 million (up $26.0 million vs. $1,526.4 million a year ago) with gross profit of $928.3 million and operating profit of $301.8 million. Diluted EPS declined to $0.55 from…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.